NCCN Risk Reclassification in Black Men with Low and Intermediate Risk Prostate Cancer After Genomic Testing-Reference-Cited by-同舟云学术

NCCN Risk Reclassification in Black Men with Low and Intermediate Risk Prostate Cancer After Genomic Testing

Published:2021-10 Issue: Volume: Page:
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Seiden Benjamin,Weng Stanley,Sun Natalie,Gordon Danielle,Harris William N.^ORCID,Barnett Jack,Myrie Akya,Jones Tashzna,Pak So Yeon,Fudl Ahd,Shields John,McNeil Brian K,Weiss Jeffrey P,Smith Matthew T.,Esdaille Ashanda R,Winer Andrew G.

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. Association between African American race and clinical outcomes in men treated for low-risk prostate cancer with active surveillance;Deka;JAMA,2020

2. Impact of race on selecting appropriate patients for active surveillance with seemingly low-risk prostate cancer;Pietzak;Urology,2015

3. Association of black race with prostate cancer-specific and other-cause mortality;Dess;JAMA Oncol,2019

4. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer;Chornokur;Prostate,2011

5. National Comprehensive Cancer Network. Prostate Cancer (Version 2.2020). https://www.nccn.org/professionals/physician_gls/pdf/prostate_blocks.pdf. Accessed August 12, 2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing;Prostate Cancer and Prostatic Diseases;2024-09-05

2. Prevalence of Genetic Mutations in Patients with Metastatic Prostate Cancer in a Cohort of Mexican Patients;Société Internationale d’Urologie Journal;2024-06-05